|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, September 27, 2011 ) West Palm Beach, FL -- Wound Management Technologies, Inc., (OTCQB: WNDM) a leader in advanced wound care solutions, today announced that its President, Deborah Hutchinson will be presenting at AdvaMed 2011: The MedTech Conference. The presentation is scheduled for Wednesday, September 28, 2011 at 9:10 in Room 204A of the Walter E. Washington Convention Center in Washington, D.C. Ms. Hutchinson's presentation will cover the 2011 results and offer the attendees insight into the growth opportunities for the Company's products both domestically and internationally.
AdvaMed 2011 brings the biggest names together to discuss the hottest topic in the MedTech industry. This year's conference plenary speakers include:
• President George W. Bush, 43rd President of the United States
• Secretary Kathleen Sebelius, Department of Health and Human Services
• Counselor John M. Taylor, III, Esq. Counselor to the Commissioner, FDA
• Governor Mitchell E. Daniels, State of Indiana
• Dr. Jeffrey E. Shuren, Director of Center for Devices and Radiological Health, FDA
• Governor Martin O'Malley, State of Maryland
Wound Management Technologies has developed a strong schedule for the three-day conference. Scheduled meetings have been arranged with several dozen potential marketing firms, investment groups, distribution partners, and commercialization groups specializing in both national and international markets. The goal of these meetings is to develop strategic partnerships to increase the knowledge and sales of CellerateRX and to assist in research and development of new product initiatives.
"We are honored to present the Wound Management story at an event that features such notable dignitaries as President Bush, Secretary Sebelius and Governors Daniels and O'Malley, among others. AdvaMed 2011 is a great opportunity for Wound Management to showcase its advanced wound care solutions to an audience of thought leaders from both industry and finance and to report on the substantial progress being made," stated Hutchinson. Also joining the meetings will be Cathy Bradshaw of WNDM subsidiary, Wound Care Innovations to participate in discussions on the company's patented collagen product, CellerateRX®
Kevin McKnight from Undiscovered Equities states, "We are excited that WNDM is able to present at such a prestigious event. This gives the Company the opportunity to network with MedTech executives from every sector of the industry."
AdvaMed 2011: The MedTech Conference runs September 26-28, 2011. For more information, visit www.AdvaMed2011.com.
AdvaMed 2011 is one of the premier MedTech conferences for business leaders, entrepreneurs, policy-makers, media, financiers, and other industry stakeholders from around the world. AdvaMed 2010 attracted 1,700 industry leaders – including many CEOs, Presidents and C-level executives. AdvaMed 2011 is designed to be a perfect event for networking; conducting partnering meetings; influencing policy makers and the media; and participating in educational sessions. For its attendees, AdvaMed 2011 can provide an introduction to many key decision-makers in the industry. For more information, visit www.AdvaMed2011.com.
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage. More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.
Undiscovered Equities is a leading provider of equity research on high impact aggressive growth investment opportunities. Our services include research analysis on the energy and precious metals markets, news and financial data, market commentary and the Undiscovered Equities newsletter. Undiscovered Equities' staff of small cap investment professionals are dedicated to providing the investment community with the tools and avenues necessary to, invest their money wisely and build wealth. To view our newsletter on a complimentary trial basis and take advantage of our other services go to www.undiscoveredequities.com and join our email list on our home page.
Disclosure/Forward Looking Statement
This release contains statements about the future, sometimes referred to as "forward-looking" statements. Forward-looking statements are typically identified by the use of the words "believe," "may," "could," "should," "expect," "anticipate," "estimate," "project," "propose," "plan," "intend," and similar words and expressions. Statements that describe our future strategic plans, goals, or objectives are also forward-looking statements. We intend that the forward-looking statements will be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Disclaimer - www.undiscoveredequities.com/disclaimer.html
Undiscovered Equities, Inc.
Kevin McKnight
561 699-0537
newsletter@undiscoveredequities.com 
Source: EmailWire.com
|
|
|
|
